David Charles Lubner

Companies

• Braveheart Bio, Inc.Board member Aug 5, 2026 to now¹
• CRESCENT BIOPHARMA, INC.Board member Jun 23, 2025 to now²
• CARGO Therapeutics, Inc.Board member Nov 9, 2023 to now³
• Arcellx, Inc.Board member Feb 3, 2022 to now⁴
• Vor Biopharma Inc.Board member Feb 4, 2021 to now⁵
• Dyne Therapeutics, Inc.Board member Sep 16, 2020 to now⁶
• POINT Biopharma Global Inc.Board member Jul 7, 2020 to Dec 27, 2023⁷
• Disc Medicine, Inc.Board member Feb 10, 2021 to Mar 9, 2022⁸
• Tetraphase Pharmaceuticals (United States)Chief financial officer Mar 19, 2013 to Aug 17, 2015⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BBBraveheart Bio, Inc. BRVE55,555 shares¹⁰$1.0M at $18.71Aug 7, 2026
• AArcellx, Inc.0 shares¹¹Apr 28, 2026
• PBPOINT Biopharma Global Inc.0 shares¹²Dec 27, 2023
• DTDyne Therapeutics, Inc. DYN0 shares¹³Apr 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 7, 2026Bought 55,555 shares at $18.00 of Braveheart Bio, Inc.¹⁰
• Apr 28, 2026U 21,659 shares of Arcellx, Inc.¹¹
• Apr 24, 2026Gift 53,625 shares of Dyne Therapeutics, Inc.¹³
• Jan 20, 2026Sold 6,000 shares at $75.00 of Arcellx, Inc.¹⁴
• Jan 20, 2026Exercised options 6,000 shares at $6.28 of Arcellx, Inc.¹⁴
• Dec 27, 2023Returned to company 3,600 shares of POINT Biopharma Global Inc.¹²
• Dec 26, 2023U 35,400 shares of POINT Biopharma Global Inc.¹²
• Nov 23, 2022Bought 3,600 shares at $6.85 of POINT Biopharma Global Inc.¹⁵
• Feb 8, 2022Converted 21,659 shares of Arcellx, Inc.¹⁶